Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-02

Clinical Trial Update: Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis [NA]

View source ↗

Summary

This clinical trial update indicates that the study evaluating topical or oral calcitriol for psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral calcitriol (calcitriol)
  • Topical calcitriol (calcitriol)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Psoriasis | NA | Status: WITHDRAWN